GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ALPHA1-antichymotrypsin variant dbs-I5: a MMP14- cleavable drug-binding serpin for doxycycline

Analyse Crystal structure of ALPHA1-antichymotrypsin variant dbs-I5: a MMP14- cleavable… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5OM3
Type
protein
Length
368 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-1-antichymotrypsin
UniProt
P01011
Ligands
DXT
Pockets
2 · best druggability 0.53

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-1-antichymotrypsinprotein33536% helix, 36% strandP01011
BAlpha-1-antichymotrypsinprotein330% helix, 58% strandP01011

Ligands and binding sites

  • DXT · (4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12A-pentahydroxy-6-methyl-1,11-dioxo-1,4,4A,5,5A,6,11,12A-octahydrotetracene-2-carboxamide · ligand · chains A, B
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11290.530.8124DXT
2770.360.7619empty

Interfaces

1 interface between chains.

  • A–B · 2449 Ų buried · 34 hydrogen bonds · protein-protein

Compared structures

  • 5OM3 · Crystal structure of Alpha1-antichymotrypsin variant DBS-I5: a MMP14-cleavable… · the same entry in another collection · chain A against A, TM-score 1.00
  • P01011 · AlphaFold monomer V2.0 prediction for alpha-1-antichymotrypsin (P01011) · a predicted model of the same protein · chain A against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.